{"count": 239, "results": [{"_id": "39460970", "pmid": 39460970, "title": "Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients.", "journal": "Pak J Pharm Sci", "authors": ["Ahmed Shaikh N", "Khakid S", "Alam M", "Hasan SS", "Rizvi F", "Mobeen K"], "date": "2024-09-01T00:00:00Z", "meta_date_publication": "2024 Sep", "meta_volume": "37", "meta_issue": "5", "meta_pages": "1033-1041", "score": 50275.594, "text_hl": "Comparative and combination study of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ alone and in combination with Beta vulgaris in @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Ahmed Shaikh N, Khakid S, Alam M, Hasan SS, Rizvi F, Mobeen K. Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients. Pak J Pharm Sci. 2024 Sep;37(5):1033-1041. PMID: 39460970", "BibTeX": "@article{39460970, title={Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients.}, author={Ahmed Shaikh N and Khakid S and Alam M and Hasan SS and Rizvi F and Mobeen K}, journal={Pak J Pharm Sci}, volume={37}, number={5}, pages={1033-1041}}"}}, {"_id": "34420300", "pmid": 34420300, "pmcid": "PMC8424683", "title": "Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form", "journal": "Mol Pharm", "authors": ["Knapik-Kowalczuk J", "Kramarczyk D", "Jurkiewicz K", "Chmiel K", "Paluch M"], "date": "2021-09-06T00:00:00Z", "doi": "10.1021/acs.molpharmaceut.1c00485", "meta_date_publication": "2021 Sep 6", "meta_volume": "18", "meta_issue": "9", "meta_pages": "3588-3600", "score": 50273.52, "text_hl": "The representative spectra of the ternary @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@EZB@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SVT@@@/@CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@FEN@@@ composition having documented the excellent therapeutic effect on mixed @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ treatment are shown in Figure 7a.", "citations": {"NLM": "Knapik-Kowalczuk J, Kramarczyk D, Jurkiewicz K, Chmiel K, Paluch M. Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form Mol Pharm. 2021 Sep 6;18(9):3588-3600. PMID: 34420300", "BibTeX": "@article{34420300, title={Ternary Eutectic Ezetimibe-Simvastatin-Fenofibrate System and the Physical Stability of Its Amorphous Form}, author={Knapik-Kowalczuk J and Kramarczyk D and Jurkiewicz K and Chmiel K and Paluch M}, journal={Mol Pharm}, volume={18}, number={9}, pages={3588-3600}}"}}, {"_id": "32410994", "pmid": 32410994, "pmcid": "PMC7201051", "title": "The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet", "journal": "Front Pharmacol", "authors": ["Zhang Q", "Fan X", "Ye R", "Hu Y", "Zheng T", "Shi R", "Cheng W", "Lv X", "Chen L", "Liang P"], "date": "2020-04-29T00:00:00Z", "doi": "10.3389/fphar.2020.00522", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "522", "score": 50273.434, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (SIM) administration could prevent HFD-induced @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@ associated with @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@.", "citations": {"NLM": "Zhang Q, Fan X, Ye R, Hu Y, Zheng T, Shi R, Cheng W, Lv X, Chen L, Liang P. The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet Front Pharmacol. 2020;11():522. PMID: 32410994", "BibTeX": "@article{32410994, title={The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet}, author={Zhang Q and Fan X and Ye R and Hu Y and Zheng T and Shi R and Cheng W and Lv X and Chen L and Liang P}, journal={Front Pharmacol}, volume={11}, pages={522}}"}}, {"_id": "35873646", "pmid": 35873646, "pmcid": "PMC9303163", "title": "Simvastatin in the Treatment of Colorectal Cancer: A Review", "journal": "Evid Based Complement Alternat Med", "authors": ["Zang H", "Yang W", "Tian X"], "date": "2022-07-14T00:00:00Z", "doi": "10.1155/2022/3827933", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "3827933", "score": 50273.31, "text_hl": "The survival benefits are then analyzed by combining the re-positioned drugs with conventional @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ treatment methods. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ is a clinically commonly used @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ drug and exerts the effect of preventing @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Zang H, Yang W, Tian X. Simvastatin in the Treatment of Colorectal Cancer: A Review Evid Based Complement Alternat Med. 2022;2022():3827933. PMID: 35873646", "BibTeX": "@article{35873646, title={Simvastatin in the Treatment of Colorectal Cancer: A Review}, author={Zang H and Yang W and Tian X}, journal={Evid Based Complement Alternat Med}, volume={2022}, pages={3827933}}"}}, {"_id": "33494472", "pmid": 33494472, "pmcid": "PMC7910921", "title": "Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment", "journal": "Pharmaceutics", "authors": ["Salem HF", "Kharshoum RM", "Abou-Taleb HA", "Farouk HO", "Zaki RM"], "date": "2021-01-21T00:00:00Z", "doi": "10.3390/pharmaceutics13020138", "meta_date_publication": "2021 Jan 21", "meta_volume": "13", "meta_issue": "2", "meta_pages": "", "score": 50272.785, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@) is a @GENE_HMGCR @GENE_3156 @@@HMG-CoA reductase@@@ inhibitor employed in the management of @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@. ", "citations": {"NLM": "Salem HF, Kharshoum RM, Abou-Taleb HA, Farouk HO, Zaki RM. Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment Pharmaceutics. 2021 Jan 21;13(2):. PMID: 33494472", "BibTeX": "@article{33494472, title={Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment}, author={Salem HF and Kharshoum RM and Abou-Taleb HA and Farouk HO and Zaki RM}, journal={Pharmaceutics}, volume={13}, number={2}}"}}, {"_id": "36475227", "pmid": 36475227, "pmcid": "PMC9717522", "title": "Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review", "journal": "Cureus", "authors": ["Chauhan D", "Memon F", "Patwardhan V", "Kotwani P", "Shah P", "Samala Venkata V"], "date": "2022-11-02T00:00:00Z", "doi": "10.7759/cureus.31007", "meta_date_publication": "2022 Nov", "meta_volume": "14", "meta_issue": "11", "meta_pages": "e31007", "score": 50269.62, "text_hl": "Comparing @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Monotherapy V/S @CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination @CHEMICAL_MESH:D000069499 @@@Simvastatin-Ezetimibe@@@ Combination Therapy for the Treatment of @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@Hyperlipidemia@@@: A Meta-Analysis and Review", "citations": {"NLM": "Chauhan D, Memon F, Patwardhan V, Kotwani P, Shah P, Samala Venkata V. Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review Cureus. 2022 Nov;14(11):e31007. PMID: 36475227", "BibTeX": "@article{36475227, title={Comparing Simvastatin Monotherapy V/S Simvastatin-Ezetimibe Combination Therapy for the Treatment of Hyperlipidemia: A Meta-Analysis and Review}, author={Chauhan D and Memon F and Patwardhan V and Kotwani P and Shah P and Samala Venkata V}, journal={Cureus}, volume={14}, number={11}, pages={e31007}}"}}, {"_id": "34243595", "pmid": 34243595, "title": "Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.", "journal": "Biomed Pharmacother", "authors": ["Abo-Zalam HB", "El-Denshary ES", "Abdelsalam RM", "Khalil IA", "Khattab MM", "Hamzawy MA"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.biopha.2021.111494", "meta_date_publication": "2021 Jul", "meta_volume": "139", "meta_issue": "", "meta_pages": "111494", "score": 50268.67, "text_hl": "Therapeutic advancement of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-loaded solid @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ nanoparticles (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@-SLNs) in treatment of @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and attenuating hepatotoxicity, @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@myopathy@@@ and apoptosis: Comprehensive study.", "citations": {"NLM": "Abo-Zalam HB, El-Denshary ES, Abdelsalam RM, Khalil IA, Khattab MM, Hamzawy MA. Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study. Biomed Pharmacother. 2021 Jul;139():111494. PMID: 34243595", "BibTeX": "@article{34243595, title={Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.}, author={Abo-Zalam HB and El-Denshary ES and Abdelsalam RM and Khalil IA and Khattab MM and Hamzawy MA}, journal={Biomed Pharmacother}, volume={139}, pages={111494}}"}}, {"_id": "34220514", "pmid": 34220514, "pmcid": "PMC8243288", "title": "Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice", "journal": "Front Pharmacol", "authors": ["Shi Y", "Feng R", "Mao J", "Liu S", "Zhou Z", "Ji Z", "Chen S", "Mao J"], "date": "2021-06-15T00:00:00Z", "doi": "10.3389/fphar.2021.689092", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "689092", "score": 50268.613, "text_hl": "Furthermore, HpT2 and @GENE_CDH17 @GENE_1015 @@@HpT1@@@ restored the alpha-diversity and structure of gut microbial community after @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@-induced microbiota disturbance compared with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and HpT3. ", "citations": {"NLM": "Shi Y, Feng R, Mao J, Liu S, Zhou Z, Ji Z, Chen S, Mao J. Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice Front Pharmacol. 2021;12():689092. PMID: 34220514", "BibTeX": "@article{34220514, title={Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice}, author={Shi Y and Feng R and Mao J and Liu S and Zhou Z and Ji Z and Chen S and Mao J}, journal={Front Pharmacol}, volume={12}, pages={689092}}"}}, {"_id": "34055199", "pmid": 34055199, "pmcid": "PMC8112934", "title": "The Beneficial Effects of Edible Kynurenic Acid from Marine Horseshoe Crab (Tachypleus tridentatus) on Obesity, Hyperlipidemia, and Gut Microbiota in High-Fat Diet-Fed Mice", "journal": "Oxid Med Cell Longev", "authors": ["Li J", "Zhang Y", "Yang S", "Lu Z", "Li G", "Wu S", "Wu DR", "Liu J", "Zhou B", "Wang HD", "Huang SY"], "date": "2021-05-03T00:00:00Z", "doi": "10.1155/2021/8874503", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "8874503", "score": 50264.96, "text_hl": "But the effects of 1.25 mg/kg/day KA on HFD-caused @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ were similar to the effects of 5 mg/kg/day @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Li J, Zhang Y, Yang S, Lu Z, Li G, Wu S, Wu DR, Liu J, Zhou B, Wang HD, Huang SY. The Beneficial Effects of Edible Kynurenic Acid from Marine Horseshoe Crab (Tachypleus tridentatus) on Obesity, Hyperlipidemia, and Gut Microbiota in High-Fat Diet-Fed Mice Oxid Med Cell Longev. 2021;2021():8874503. PMID: 34055199", "BibTeX": "@article{34055199, title={The Beneficial Effects of Edible Kynurenic Acid from Marine Horseshoe Crab (Tachypleus tridentatus) on Obesity, Hyperlipidemia, and Gut Microbiota in High-Fat Diet-Fed Mice}, author={Li J and Zhang Y and Yang S and Lu Z and Li G and Wu S and Wu DR and Liu J and Zhou B and Wang HD and Huang SY}, journal={Oxid Med Cell Longev}, volume={2021}, pages={8874503}}"}}, {"_id": "34749751", "pmid": 34749751, "pmcid": "PMC8573942", "title": "Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia", "journal": "Lipids Health Dis", "authors": ["Sivkov A", "Chernus N", "Gorenkov R", "Sivkov S", "Sivkova S", "Savina T"], "date": "2021-11-08T00:00:00Z", "doi": "10.1186/s12944-021-01586-7", "meta_date_publication": "2021 Nov 8", "meta_volume": "20", "meta_issue": "1", "meta_pages": "157", "score": 50263.426, "text_hl": "Relationship between genetic polymorphism of drug transporters and the efficacy of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hyperlipidemias</m> @DISEASE_MESH:D006949 @@@hyperlipidemia@@@", "citations": {"NLM": "Sivkov A, Chernus N, Gorenkov R, Sivkov S, Sivkova S, Savina T. Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia Lipids Health Dis. 2021 Nov 8;20(1):157. PMID: 34749751", "BibTeX": "@article{34749751, title={Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia}, author={Sivkov A and Chernus N and Gorenkov R and Sivkov S and Sivkova S and Savina T}, journal={Lipids Health Dis}, volume={20}, number={1}, pages={157}}"}}]}